PREDICTIVE BIOMARKER FOR CANCER TREATMENT WITH ADCC-ENHANCED ANTIBODIES
摘要
<p>The present invention is directed to methods for identifying which patients diagnosed with cancer will most benefit from treatment with an anti-cancer therapy comprising an ADCC- enhanced antibody.</p>
申请公布号
WO2014114595(A1)
申请公布日期
2014.07.31
申请号
WO2014EP51034
申请日期
2014.01.20
申请人
ROCHE GLYCART AG
发明人
DI SCALA, LILLA;EVERS, STEFAN;GERDES, CHRISTIAN;MANCAO, CHRISTOPH;PASSIOUKOV, ALEXANDRE;UMANA, PABLO
